Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-01-18 Purchase | 2023-01-20 4:58 pm | UNITED STATES ANTIMONY CORP | UAMY | EVANS GARY C Director | 21,368 | $0.45 | $9,616 | 956,849 (Direct) | View |
| 2023-01-11 Purchase | 2023-01-17 06:03 am | UNITED STATES ANTIMONY CORP | UAMY | EVANS GARY C Director | 26,081 | $0.45 | $11,736 | 904,112 (Direct) | View |
| 2023-01-13 Purchase | 2023-01-17 06:03 am | UNITED STATES ANTIMONY CORP | UAMY | EVANS GARY C Director | 31,369 | $0.45 | $14,116 | 935,481 (Direct) | View |
| 2022-12-10 Purchase | 2022-12-21 12:19 pm | UNITED STATES ANTIMONY CORP | UAMY | EVANS GARY C Director | 161,993 | $0.45 | $72,897 | 878,031 (Direct) | View |
| 2022-12-15 Purchase | 2022-12-16 2:50 pm | UNITED STATES ANTIMONY CORP | UAMY | EVANS GARY C Director | 119,201 | $0.45 | $53,640 | 835,239 (Direct) | View |
| 2022-12-13 Purchase | 2022-12-15 5:05 pm | UNITED STATES ANTIMONY CORP | UAMY | EVANS GARY C Director | 307,202 | $0.45 | $138,241 | 716,038 (Direct) | View |
| 2022-12-07 Purchase | 2022-12-12 2:16 pm | UNITED STATES ANTIMONY CORP | UAMY | EVANS GARY C Director | 368,836 | $0.40497 | $149,369 | 408,836 (Direct) | View |
| 2022-12-06 Purchase | 2022-12-09 3:27 pm | UNITED STATES ANTIMONY CORP | UAMY | EVANS GARY C Director | 40,000 | $0.38 | $15,200 | 40,000 (Direct) | View |
| 2021-06-01 Sale | 2021-06-03 5:34 pm | NOVAVAX INC | EVANS GARY C Director | 625 | $146.5 | $91,563 | 16,099 (Indirect Direct) | View | |
| 2021-03-15 Sale | 2021-03-17 6:36 pm | NOVAVAX INC | EVANS GARY C Director | 24,500 | $211.21 | $5,174,536 | 16,724 (Indirect Direct) | View | |
| 2020-08-18 Sale | 2020-08-20 6:09 pm | NOVAVAX INC | EVANS GARY C Director | 10,500 | $150.44 | $1,579,620 | 329,979 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2021-06-17 Exercise | 2021-06-22 5:12 pm | N/A N/A | NOVAVAX INC | EVANS GARY C Director | 3,450 | $0 | 19,549 (Direct) | View | |
| 2021-03-15 Exercise | 2021-03-17 6:36 pm | N/A N/A | NOVAVAX INC | EVANS GARY C Director | 4,500 | $46 | 16,724 (Direct) | View | |
| 2021-03-15 Exercise | 2021-03-17 6:36 pm | N/A N/A | NOVAVAX INC | EVANS GARY C Director | 2,000 | $99.8 | 16,724 (Direct) | View | |
| 2021-03-15 Exercise | 2021-03-17 6:36 pm | 2016-09-15 2026-03-15 | NOVAVAX INC | EVANS GARY C Director | 24,500 | $0 | 16,724 (Direct) | View | |
| 2021-03-15 Exercise | 2021-03-17 6:36 pm | N/A N/A | NOVAVAX INC | EVANS GARY C Director | 18,000 | $3.985 | 16,724 (Direct) | View | |
| 2020-08-18 Exercise | 2020-08-20 6:09 pm | N/A N/A | NOVAVAX INC | EVANS GARY C Director | 1,500 | $36.6 | 329,979 (Direct) | View | |
| 2020-08-18 Exercise | 2020-08-20 6:09 pm | N/A N/A | NOVAVAX INC | EVANS GARY C Director | 4,000 | $27.6 | 329,979 (Direct) | View | |
| 2020-08-18 Exercise | 2020-08-20 6:09 pm | 2011-09-10 2021-03-10 | NOVAVAX INC | EVANS GARY C Director | 10,500 | $0 | 329,979 (Direct) | View | |
| 2020-08-18 Exercise | 2020-08-20 6:09 pm | N/A N/A | NOVAVAX INC | EVANS GARY C Director | 1,000 | $50 | 329,979 (Direct) | View | |
| 2020-06-25 Option Award | 2020-06-26 9:17 pm | 2021-06-25 2030-06-25 | NOVAVAX INC | EVANS GARY C Director | 10,350 | $0 | 10,350 (Direct) | View | |
| 2019-12-12 Option Award | 2019-12-16 4:59 pm | 2020-12-12 2029-12-12 | NOVAVAX INC | EVANS GARY C Director | 18,000 | $0 | 18,000 (Direct) | View |